Month: November 2018
The Diagnostic and Interventional Cardiology website posted an important article about recent proposed changes by the FDA which may allow Institutional Review Boards (IRB) to waive or alter informed consent requirements for clinical studies that pose minimal risk to human participants. The conditions under which an IRB could do this are limited and detailed in the…
Read More
Meet with Christopher Kata, Director of Sales & Marketing on December 11th & 12th 2018 DEVICETALKS West ! Christopher Kata, Director of Sales & Marketing 905 999-1957 [email protected] When: December 11th & 12th 9:00 am – 5:30 pm Where: HILTON ORANGE COUNTY / COSTA MESA, 3050 Bristol St, Costa Mesa, CA 92626 Registration: https://west.devicetalks.com/ …
Read More
Meet with Christopher Kata, Director of Sales & Marketing on November 13th at the OBIO Event “Talking to Doctors & Patients: Using Primary Market Research Data to Seal the Deal with Investors”! Christopher Kata, Director of Sales & Marketing 905 999-1957 [email protected] When: November 13th 11:00 am – 2:00 pm Where: 100 College St Suite 150…
Read More